We are monitoring the impact of COVID-19 on Latin America Liquid Biopsy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 893
Share on
Share on

Latin America Liquid Biopsy Market Research Report – Segmented By Cancer Type, Sample Type, Diagnostic Approach, End Users, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 893
Pages: 145

Latin America Liquid Biopsy Market Size (2021 to 2026)

The Latin American Liquid Biopsy Market size is predicted to grow at a CAGR of 27.6% during the forecast period. The market size is projected to value USD 648.30 million by 2026 from USD 191.66 million in 2021.

The growth of the Latin American Liquid Biopsy Market is majorly driven by the increasing number of infectious diseases and increased focus on developing new technologies in the healthcare domain. Growing prominence for developing novel diagnostics tools for various cancer cases is also ascribed to bolster the market's demand. Growing investments in healthcare to develop accurate techniques by private and public organizations propel the market's growth rate. Additionally, the increasing prevalence of companion diagnostics and the rising demand to develop innovative technologies in favor of the end-users are anticipated to fuel the market's demand. Favorable reimbursement policies and increasing awareness over precision medicine utilization are further flourishing the growth rate of the liquid biopsy market in Latin America.

Secondarily, the rising prevalence of cancer, preference for invasive procedures, and funding in research and development for advancement in the liquid biopsy are anticipated to increase market demand. These are some of the factors driving the growth of this market in Brazil. Furthermore, liquid biopsy can detect cancer early, which helps the doctors provide proper treatment procedures, which is lucratively prompting market growth in Mexico.

Stringent government policies and transportation restrictions due to lockdown are causing downturn growth of the liquid biopsy market. COVID-19 outbreak is emphasizing the companies to develop new techniques. Novel Coronavirus can leave long-term effects on trade practices even after the Liquid Biopsy market lockdown period.

However, factors like the dearth of skilled persons and lack of proper knowledge in rural areas hinder the market's growth rate. In addition, the high cost of installing and maintaining the devices in the clinical laboratories is slowly impeding the demand of the liquid biopsy market. Growing complications in the real-time monitoring procedures are slowly hampering the demand of the market in Latin America. Besides, people in rural areas are less aware of the treatment procedures available, which is gradually limiting the market's growth rate.

This research report on the Latin American Liquid Biopsy Market has been segmented and sub-segmented market into the following categories:

By Cancer Type: 

  • Lung Cancer
  • Pancreatic Cancer
  • Leukemia
  • Other Visceral Cancers

By Diagnostic Approach: 

  • Circulating Tumour cells (CTC)
  • Circulating Tumour DNA (ctDNA)
  • RNA in exosomes
  • Extra-Cellular Vesicles

By End-Users: 

  • Reference Laboratories
  • Hospital/Physician Laboratories
  • Academic and Research Centers
  • Other End Users

By Country: 

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Geographically, the Brazilian market is the largest contributor to the Latin American liquid biopsy market. In Brazil, factors like the rising prevalence of different types of cancer and quick diagnostic technology requirements enable market growth. The growing geriatric population has elevated the demand for the liquid biopsy market. Strong Government support, increased mortality rate due to cancer, and improving healthcare infrastructure drive the market's growth in this part of the world. For a country like Brazil, with a large and aging population, new technologies take time. Therefore, spreading awareness in a rural area is needed to grow the market.

In Mexico, growth in patients who have cancer is fueling the market demand. Cancer is the second leading cause of death. In addition, higher alcohol consumption leads to develop lung, colorectal, breast, and prostate cancer. These factors are accelerating the growth of the liquid biopsy market in this region.


A few prominent companies operating in the Latin America Liquid Biopsy Market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                           

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                              

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                            

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                     

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                      

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                                              

                5.1 By Cancer Type                                                         

                                5.1.1 Lung Cancer                                           

                                5.1.2 Pancreatic Cancer                                

                                5.1.3 Leukemia                                

                                5.1.4 Other Visceral Cancers                                       

                5.2 By Sample Type                                                        

                                5.2.1 Blood                                        

                                5.2.2 Urine                                         

                                5.2.3 Plasma                                      

                                5.2.4 Saliva                                         

                                5.2.5 Cerebrospinal                                        

                5.3 By Diagnostic Approach                                                        

                                5.3.1 Circulating Tumour cells (CTC)                                        

                                5.3.2 Circulating Tumour DNA (ctDNA)                                  

                                5.3.3 RNA in exosomes                                 

                                5.3.4 Extra-Cellular Vesicles                                        

                5.4 By End Users                                                             

                                5.4.1 Reference Laboratories                                     

                                5.4.2 Hospital/Physician Laboratories                                     

                                5.4.3 Academic and Research Centers                                    

                                5.4.4 Other End Users                                   

6. Geographical Analysis                                                                              

                                6.1 Introduction                                              

                                6.2 Brazil                                             

                                6.3 Mexico                                         

                                6.4 Argentina                                    

                                6.5 Rest of Latin America                                             

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                      

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                               

                                7.2.5 Competitive Rivalry within the Industry                                      

8. Market Leaders' Analysis                                                                        

                8.1 Janssen Diagnostics                                                

                                8.1.1 Overview                                

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                            

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen                                                         

                8.3 Rarecells SAS                                                             

                8.4 Silicon Biosystems                                                   

                8.5 SRI International                                                      

                8.6 Myriad Genetics                                                      

                8.7 Natera                                                          

                8.8 Personal Genome Diagnostics                                                            

                8.9 Sysmex Inostics                                                        

                8.10 Trovagene                                                

                8.11 Exosome Diagnostics                                                           

                8.12 HansaBiomed OU                                                  

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                          

                9.4 New Product Launches                                                          

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 


                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Liquid Biopsy Market, By Region, From 2021 to 2026 (USD Billion)
  2. Latin America Liquid Biopsy Market, By Cancer Type, From 2021 to 2026 (USD Billion)
  3. Latin America Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  5. Latin America Leukemia Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Other Visceral Cancers Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America Liquid Biopsy Market, By Sample Type, From 2021 to 2026 (USD Billion)
  8. Latin America Blood Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Urine Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Plasma Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America Saliva Market, By Region, From 2021 to 2026 (USD Billion)
  12. Latin America Cerebrospinal Market, By Region, From 2021 to 2026 (USD Billion)
  13. Latin America Liquid Biopsy Market, By Diagnostic Approach, From 2021 to 2026 (USD Billion)
  14. Latin America Circulating Tumour cells (CTC) Market, By Region, From 2021 to 2026 (USD Billion)
  15. Latin America Circulating Tumour DNA (ctDNA) Market, By Region, From 2021 to 2026 (USD Billion)
  16. Latin America RNA in exosomes Market, By Region, From 2021 to 2026 (USD Billion)
  17. Latin America Extra-Cellular Vesicles Market, By Region, From 2021 to 2026 (USD Billion)
  18. Latin America Liquid Biopsy Market, By End Users, From 2021 to 2026 (USD Billion)
  19. Latin America Reference Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  20. Latin America Hospital/Physician Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  21. Latin America Academic and Research Centers Market, By Region, From 2021 to 2026 (USD Billion)
  22. Latin America Other End Users Market, By Region, From 2021 to 2026 (USD Billion)
  23. Brazil Liquid Biopsy Market, By Cancer Type, From 2021 to 2026 (USD Billion)
  24. Brazil Liquid Biopsy Market, By Sample Type, From 2021 to 2026 (USD Billion)
  25. Brazil Liquid Biopsy Market, By Diagnostic Approach, From 2021 to 2026 (USD Billion)
  26. Brazil Liquid Biopsy Market, By End Users, From 2021 to 2026 (USD Billion)
  27. Argentina Liquid Biopsy Market, By Cancer Type, From 2021 to 2026 (USD Billion)
  28. Argentina Liquid Biopsy Market, By Sample Type, From 2021 to 2026 (USD Billion)
  29. Argentina Liquid Biopsy Market, By Diagnostic Approach, From 2021 to 2026 (USD Billion)
  30. Argentina Liquid Biopsy Market, By End Users, From 2021 to 2026 (USD Billion)
  31. Mexico Liquid Biopsy Market, By Cancer Type, From 2021 to 2026 (USD Billion)
  32. Mexico Liquid Biopsy Market, By Sample Type, From 2021 to 2026 (USD Billion)
  33. Mexico Liquid Biopsy Market, By Diagnostic Approach, From 2021 to 2026 (USD Billion)
  34. Mexico Liquid Biopsy Market, By End Users, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample